Patents/Assignees

A2 BIOTHERAPEUTICS, Inc.

13 patents in portfolio

US12599665utility2026
Gene Fusions for Control of Genetically Modified Cells
0 cites
US12595291utility2026
Engineered Immune Cells with Micro-clusters
0 cites
US12534509utility2026
Engineered Immune Cells with Receptor Cross-talk
0 cites
US12459983utility2025
Engineered Immune Cells with Receptor Signal Strength Modulated by a Hinge
0 cites
US12435124utility2025
Compositions and Methods for Treating CEACAM Positive Cancers
0 cites
US12215134utility2025
Engineered Immune Cells with Dominant Signals
0 cites
US12187775utility2025
Lilrb1-based Chimeric Antigen Receptor
0 cites
US12037377utility2024
Lilrb1-based Chimeric Antigen Receptor
0 cites
US12012612utility2024
Engineered Immune Cells with Receptor Signal Strength Modulated by a Hinge
0 cites
US11976297utility2024
Engineered Immune Cells with Receptor Cross-talk
0 cites
US11730764utility2023
Compositions and Methods for Treating HER2 Positive Cancers
0 cites
US11602543utility2023
Compositions and Methods for Treating Mesothelin Positive Cancers
0 cites
US11602544utility2023
Compositions and Methods for Treating EGFR Positive Cancers
0 cites